Tag: Clinical evaluation

Merck

Merck and Ridgeback Bio collaborate to develop novel antiviral candidate, EIDD-2801

0
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics LP, a closely held biotechnology company, announced that the companies have...

This function has been disabled for HealthTekPak.

error: Content is protected !!